Fundz

Theranica Secures $45 Million Series C Funding Round

PRIVATEAug 29, 2022

Amount Raised

$45 Million

Round Type

Series C

BiotechnologyHealth CareTherapeutics

Description

Theranica, a prescribed digital therapeutics company developing advanced neuromodulation devices for migraine and other idiopathic pain conditions, today announced the closing of its Series C funding round, with a first closing of $45 million.

Quick answer

Theranica raised $45 Million in a Series C round, dated August 29, 2022.

How much did Theranica raise?
Theranica raised $45 Million in a Series C round on August 29, 2022.
What does Theranica do?
Theranica is a prescribed digital therapeutics company dedicated to creating effective, safe, affordable, low-side effect therapies for idiopathic pain conditions.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Theranica that raised within 45 days of this round, from Fundz verified event records.

  • CTRL Therapeutics raised $7.5M on October 12, 2022.
  • Neumora raised $112M (Series B) on October 11, 2022.
  • RadioMedix raised $40M (Series A) on October 7, 2022.
  • NewcelX raised $4M (Seed) on October 7, 2022.
  • Valitor raised an undisclosed amount (Series B) on October 5, 2022.
  • Vergent Bioscience raised $22M (Series B) on October 4, 2022.

Who to call at Theranica, and when

A new round usually means Theranica is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Theranica raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Theranica, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Theranica. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Theranica

About

Theranica is a prescribed digital therapeutics company dedicated to creating effective, safe, affordable, low-side effect therapies for idiopathic pain conditions. The company's award-winning flagship product, Nerivio®, is the first FDA-cleared smartphone-controlled prescribed wearable device for acute treatment of migraine, recently surpassed a quarter of a million treatments administered to date. Theranica is expanding its proprietary technology to develop solutions for additional idiopathic pain conditions. Nerivio has received FDA authorization and CE mark for use in acute treatment of episodic and chronic migraine in adult and adolescent patients. Learn more by visiting our websites, theranica.com, nerivio.com and following us on LinkedIn, Twitter, Instagram and Facebook.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Theranica raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Theranica's next move

See what Strategic adds

Theranica raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.